Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.

Man, Cheuk-Him

Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma. [electronic resource] - The Journal of pathology Feb 2012 - 471-81 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1096-9896

10.1002/path.2997 doi


Animals
Antineoplastic Agents--pharmacology
Apoptosis--physiology
Carcinoma
Cell Line, Tumor
Cell Proliferation
Cell Transformation, Neoplastic--drug effects
Cisplatin--pharmacology
Epstein-Barr Virus Infections--complications
Gene Knockdown Techniques
Genes, Neoplasm--physiology
Humans
Inhibitor of Apoptosis Proteins--metabolism
Mice
Mice, Nude
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms--drug therapy
Neoplasm Transplantation
RNA, Small Interfering--metabolism
Receptor, Notch3
Receptors, Notch--antagonists & inhibitors
Signal Transduction--physiology
Spheroids, Cellular--physiology
Transfection
Transplantation, Heterologous